Joel Lewis

CEO

Board Member

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

Affiliation history

Recorded current and former roles; source labels appear when available.

Recorded roles and earnings-call appearances connecting this person to public companies.

GALT

Current role

CEO, Board Member

2017-01-01–present

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2024	Galectin Therapeutics Inc (GALT)	Chief Executive Officer & President	$620,167	$312,000	$202,635	—	—	$54,872	$1,189,674
2023	Galectin Therapeutics Inc (GALT)	Chief Executive Officer & President	$573,583	$289,000	—	$55,924	—	$45,140	$963,647
2022	Galectin Therapeutics Inc (GALT)	Chief Executive Officer & President	$522,917	$262,500	—	$103,517	—	$85,247	$974,181
2021	Galectin Therapeutics Inc (GALT)	Chief Executive Officer & President	$500,000	$250,000	—	$329,177	—	$88,444	$1,167,621
2020	Galectin Therapeutics Inc (GALT)	Chief Executive Officer & President	$164,773	$75,000	—	$486,125	—	$27,660	$753,558

No earnings-call appearances or filed executive changes recorded yet.